End TB Clin.Trial Output 2

de Jong, Bouke (Promotor)
Janssens, Nancy (Administrator)
Ardizzoni, Elisa (PI)

1 A1: Peer-reviewed journal articles

1 results

Filter

2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
Guglielmetti, L., Ardizzoni, E., Atger, M., Baudin, E., Berikova, E., Bonnet, M., Chang, E., Cloez, S., Coit, J. M., Cox, J., de Jong, B. C., Delifer, C., Do, J. M., Tozzi, D. D. S., Ducher, Ferlazzo, G., Gouillou, M., Khan, A., Khan, U. & Lachenal, N. & 24 others, LaHood, A. N., Lecca, L., Mazmanian, M., McIlleron, H., Moschioni, M., O'Brien, K., Okunbor, O., Oyewusi, L., Panda, S., Patil, S. B., Phillips, P. P. J., Pichon, L., Rupasinghe, P., Rich, M. L., Saluhuddin, N., Seung, K. J., Tamirat, M., Trippa, L., Cellamare, M., Velasquez, G. E., Wasserman, S., Zimetbaum, P. J., Varaine, F. & Mitnick, C. D., 2021, In: Trials. 22, 1, 15 p., 651.
Research output: Contribution to journal › A1: Peer-reviewed journal articles › peer-review

Open Access
File
86 Downloads (Pure)